Publicaciones científicas

Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

Garcia-Velloso MJ (1), Bastarrika G (2), de-Torres JP (3), Lozano MD (4), Sanchez-Salcedo P (5), Sancho L (6), Nuñez-Cordoba JM (7), Campo A (3), Alcaide AB (3), Torre W (8), Richter JA (6), Zulueta JJ (3).
(1) Department of Nuclear Medicine, Clinica Universidad de Navarra, Pamplona, Spain.
(2) Department of Radiology, Clinica Universidad de Navarra, Pamplona, Spain.
(3) Department of Pulmonology, Clinica Universidad de Navarra, Pamplona, Spain.
(4) Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain.
(5) Department of Pulmonology, Complejo Hospitalario de Navarra, Pamplona, Spain.
(6) Department of Nuclear Medicine, Clinica Universidad de Navarra, Pamplona, Spain.
(7) Division of Biostatistics, Research Support Service, Central Clinical Trials Unit, Clinica Universidad de Navarra, Department of Preventive Medicine and Public Health, Medical School, University of Navarra, Pamplona, Spain.
(8) Department of Thoracic Surgery, Clinica Universidad de Navarra, Pamplona, Spain. 

Revista: Lung Cancer

Fecha: 02-may-2016

Radiología Neumología Medicina Nuclear Anatomía Patológica Cirugía Torácica

BACKGROUND:
A major drawback of lung cancer screening programs is the high frequency of false-positive findings on computed tomography (CT). We investigated the accuracy of selective 2-[fluorine-18]-fluoro-2-deoxy-d-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) scan in assessing radiologically indeterminate lung nodules detected in lung cancer screening.

METHODS:
FDG PET/CT was performed to characterize 64 baseline lung nodules >10mm and 36 incidence nodules detected on low-dose CT screening in asymptomatic current or former smokers (83 men, age range 40-83 years) at high risk for lung cancer. CT images were acquired without intravenous contrast.

Nodules were analyzed by size, density, and metabolic activity and visual scored on a 5-point scale for FDG uptake. Nodules were classified as negative for malignancy when no FDG uptake was observed, or positive when focal uptake was observed in the visual analysis, and the maximum standardized uptake value (SUVmax) was measured. Final diagnosis was based on histopathological evaluation or at least 24 months of follow-up.

RESULTS:
A total of 100 nodules were included. The prevalence of lung cancer was 1%. The sensitivity, specificity, NPV and PPV of visual analysis to detect malignancy were 84%, 95%, 91%, and 91%, respectively, with an accuracy of 91% (AUC 0.893). FDG PET/CT accurately detected 31 malignant tumors (diameters 9-42mm, SUVmax range 0.6-14.2) and was falsely negative in 6 patients. With SUVmax thresholds for malignancy of 1.5, 2, and 2.5, specificity was 97% but sensitivity decreased to 65%, 49%, and 46% respectively, and accuracy decreased to 85%, 79%, and 78% respectively (AUC 0.872).

CONCLUSIONS:
The visual analysis of FDG PET/CT scan is highly accurate in characterizing indeterminate pulmonary nodules detected in lung cancer screening with low-dose CT. Semi-quantitative analysis does not improve the accuracy of FDG PET/CT over that obtained with a qualitative method for lung nodule characterization.

CITA DEL ARTÍCULO  Lung Cancer. 2016 Jul;97:81-6. doi: 10.1016/j.lungcan.2016.04.025. Epub 2016 May 2.

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra